The role of 18F-FDG PET/CT in detecting metastatic deposits of recurrent medullary thyroid carcinoma: A prospective study
- 31 May 2008
- journal article
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 34 (5) , 581-586
- https://doi.org/10.1016/j.ejso.2007.08.005
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Le carcinome médullaire de la thyroïde: les nouvelles approches thérapeutiquesAnnales d'Endocrinologie, 2007
- Diagnostic accuracy of 18F-FDG PET in restaging patients with medullary thyroid carcinoma and elevated calcitonin levels.Journal of Nuclear Medicine, 2007
- Detection of Occult Medullary Thyroid Cancer Recurrence with 2-Deoxy-2-[F-18]fluoro-d-glucose-PET and PET/CTMolecular Imaging & Biology, 2006
- Prognosis of medullary thyroid carcinomaCancer, 2006
- Medullary Thyroid Carcinoma – Update and Present Management ControversiesThe Annals of The Royal College of Surgeons of England, 2006
- Medullary Thyroid CancerSurgical Oncology Clinics of North America, 2006
- Evaluation of the pharmacokinetics of 68Ga-DOTATOC in patients with metastatic neuroendocrine tumours scheduled for 90Y-DOTATOC therapyEuropean Journal of Nuclear Medicine and Molecular Imaging, 2006
- Review of Fluorine-18-2-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography (FDG-PET) in the Follow-Up of Medullary and Anaplastic Thyroid CarcinomasCancer Control, 2005
- Impact of 18F-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography (FDG-PET) in Patients with Biochemical Evidence of Recurrent or Residual Medullary Thyroid CancerAnnals of Surgical Oncology, 2004
- 18F-FDG PET, somatostatin receptor scintigraphy, and CT in metastatic medullary thyroid carcinoma: a clinical study and an analysis of the literatureNuclear Medicine Communications, 2004